Haleon Plc is a leading pharmaceutical company based in the United Kingdom, ranking low on the ESG score scale with a score of 14.9. The company is a key player in the consumer health industry, having separated from GSK and gone public in July 2022. Haleon's product portfolio includes well-known global brands such as Sensodyne, Advil, Centrum, and Poligrip, as well as regional brands like Emergen-C, Eno, Tums, and Caltrate. With a focus on oral care, digestive health, pain relief, and nutrition, Haleon is a powerhouse in the pharmaceutical sector.